Epidemiology and Physiopathology of Oncogenic Viruses, Institut Pasteur, CNRS URA 3015, 28 rue du Dr Roux, 75724 Paris cedex 15, France.
Molecular Retrovirology Unit, Institut Pasteur, CNRS URA 3015, 28 rue du Dr Roux, 75724 Paris cedex 15, France.
J Gen Virol. 2012 Dec;93(Pt 12):2646-2651. doi: 10.1099/vir.0.045146-0. Epub 2012 Sep 19.
RNA editing mediated by adenosine deaminases acting on RNA (ADARs) converts adenosine (A) to inosine (I) residues in dsRNA templates. While ADAR-1-mediated editing was essentially described for RNA viruses, the present work addresses the issue for two δ-retroviruses, human T-cell leukemia virus type 2 and simian T-cell leukemia virus type 3 (HTLV-2 and STLV-3). We examined whether ADAR-1 could edit HTLV-2 and STLV-3 virus genomes in cell culture and in vivo. Using a highly sensitive PCR-based method, referred to as 3DI-PCR, we showed that ADAR-1 could hypermutate adenosine residues in HTLV-2. STLV-3 hypermutation was obtained without using 3DI-PCR, suggesting a higher mutation frequency for this virus. Detailed analysis of the dinucleotide editing context showed preferences for 5' ArA and 5' UrA. In conclusion, the present observations demonstrate that ADAR-1 massively edits HTLV-2 and STLV-3 retroviruses in vitro, but probably remains a rare phenomenon in vivo.
腺苷脱氨酶作用于 RNA 的 RNA 编辑(ADARs)将双链 RNA 模板中的腺苷(A)转换为肌苷(I)残基。虽然 ADAR-1 介导的编辑主要针对 RNA 病毒进行了描述,但本工作针对两种 δ-逆转录病毒,即人类 T 细胞白血病病毒 2 型和猿猴 T 细胞白血病病毒 3 型(HTLV-2 和 STLV-3)进行了研究。我们研究了 ADAR-1 是否可以在细胞培养和体内编辑 HTLV-2 和 STLV-3 病毒基因组。使用一种高度敏感的基于 PCR 的方法,称为 3DI-PCR,我们表明 ADAR-1 可以使 HTLV-2 中的腺苷残基发生超突变。未使用 3DI-PCR 即可获得 STLV-3 的突变,表明该病毒的突变频率更高。对二核苷酸编辑上下文的详细分析显示出对 5' ArA 和 5' UrA 的偏好。总之,本研究表明 ADAR-1 在体外大量编辑 HTLV-2 和 STLV-3 逆转录病毒,但在体内可能仍然是罕见现象。